0001411920-17-000001.txt : 20170112 0001411920-17-000001.hdr.sgml : 20170112 20170111180054 ACCESSION NUMBER: 0001411920-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170112 DATE AS OF CHANGE: 20170111 EFFECTIVENESS DATE: 20170112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRX Therapeutics, Inc. CENTRAL INDEX KEY: 0001411920 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-278212 FILM NUMBER: 17523659 BUSINESS ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: SUITE 1601 CITY: New York STATE: NY ZIP: 10065 BUSINESS PHONE: 212-582-1199 MAIL ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: SUITE 1601 CITY: New York STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: IRX Therapeutics Inc DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0707 D LIVE 0001411920 IRX Therapeutics, Inc. 654 MADISON AVENUE SUITE 1601 New York NY NEW YORK 10065 212-582-1199 DELAWARE IRX Therapeutics Inc Corporation true Jeffrey Hwang c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer Curtis P. Robb c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer Zygmund Roth c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer John W. Hadden II c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer Director David H. Deming c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director George P. Denny III c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director John D. Halpern c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Ferid Murad c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Lawrence M. Wolf c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Charles R. Cherington c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Biotechnology Decline to Disclose 06b false 2016-12-30 false true false 0 13237234 13237234 0 false 68 0 0 0 true false IRX Therapeutics, Inc. Curtis P. Robb Curtis P. Robb Chief Financial Officer 2017-01-11